Physician profile
Shoba Narayan
NPI 1841516093
$505.68
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $151 · 2020: $64.37 · 2022: $132 · 2023: $76.01 · 2024: $82.77.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $159.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $158.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $130.67 | 2022 | |
| Kyowa Kirin, INC. | $81.73 | 2023-2024 | Crysvita |
| Antares Pharma, INC. | $41.97 | 2019-2020 | |
| Amgen INC. | $41.02 | 2019 | |
| Novartis Pharmaceuticals Corporation | $37.13 | 2019 | |
| Nxstage Medical, INC. | $28.77 | 2023 | Nxstage System One |
| Alnylam Pharmaceuticals INC. | $28.69 | 2024 | Oxlumo |
| Silvergate Pharmaceuticals, INC. | $26.52 | 2019 | |
| Greenwich Biosciences, INC. | $23.68 | 2019 | |
| Alexion Pharmaceuticals, INC. | $22.19 | 2020 | |
| Azurity Pharmaceuticals, INC. | $19.59 | 2023 | Katerzia |
| Travere Therapeutics, INC. | $12.60 | 2020-2022 | |
| Cumberland Pharmaceuticals, INC. | $11.12 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shoba Narayan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.